WeVote

Bill

Bill

SP 798

Joint Order, To Recall From The Governor'S Desk To The Senate L.D. 1018, An Act To Protect Health Care For Rural And Underserved Areas By Prohibiting Discrimination By Participants In A Federal Drug Discount Program

132nd Legislature (2025-2026) Introduced by Donna Bailey

Maine recalls pharmaceutical discrimination bill to protect rural healthcare provider access to federal drug discount programs for medication affordability.

In concurrence. ORDERED SENT FORTHWITH.
0
WeVote Research Nonpartisan
Bill Summary · SP 798

Legislative bill overview

This joint order recalls L.D. 1018 from the Governor's desk back to the Maine Senate for further consideration. L.D. 1018 itself prohibits discrimination against healthcare providers in rural and underserved areas who participate in federal drug discount programs, ensuring these regions maintain access to discounted medications.

Why is this important

Rural and underserved communities often face barriers to healthcare access and affordability. This bill prevents pharmaceutical discount programs from excluding or disadvantaging providers serving these populations, which could protect medication access for vulnerable populations and support healthcare infrastructure in economically stressed areas.

Potential points of contention

  • Program participation requirements: Drug manufacturers may argue that uniform discount program standards are necessary for cost control and that regional carve-outs create administrative complexity
  • Definition ambiguity: Questions about what constitutes "discrimination" and which areas qualify as "rural or underserved" could create implementation disputes
  • Federal authority concerns: The bill's relationship to existing federal drug discount program rules (like 340B program regulations) and whether state action can effectively override federal framework requirements

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.